Bullish option flow detected in Viatris with 12,671 calls trading, 5x expected, and implied vol increasing over 1 point to 34.80%. Oct-23 11 calls and Nov-23 10 calls are the most active options, with total volume in those strikes near 11,900 contracts. The Put/Call Ratio is 0.02. Earnings are expected on November 6th.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VTRS:
- Viatris and Ocuphire announce FDA approved RYZUMVI to treat mydriasis
- Ocuphire Pharma, Viatris announce FDA approval of RYZUMVI
- Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
- Viatris in talks to sell European OTC assets to CVC, Bloomberg says
- Viatris (NASDAQ:VTRS) Gains on Tentative Approval for HIV Treatment